Emily Lawson DBE | |
---|---|
Education | North London Collegiate School Westminster School |
Alma mater | Gonville and Caius College, Cambridge University of East Anglia University of Oxford University of Pennsylvania |
Scientific career | |
Institutions | NHS England |
Thesis | Molecular and genetic analysis of a modified Ac transposon in Arabidopsis. (1993) |
Dame Emily Jane Ruth Lawson DBE is a British management consultant and the interim Chief Operating Officer of NHS England. Lawson led the initial rollout of the NHS COVID-19 vaccine programme in 2020 and the subsequent booster programme in 2021. Prior to this, she worked for McKinsey & Company, Morrisons, and Kingfisher plc in human resources.
Lawson was born in Westminster, London in March 1967. [1] She attended North London Collegiate School and Westminster School.[ citation needed ] She is Jewish. [2] She studied Natural Sciences at Gonville and Caius College, University of Cambridge graduating with a first in 1989. [3] While there she was president of the Caius Science Society in her final year. [4] She then completed a doctorate in molecular genetics at the John Innes Centre, University of East Anglia, with a thesis on transposons in Arabidopsis in 1993. [3] [5] [6] After this, she undertook a two-year postdoctoral fellowship at the University of Pennsylvania and then worked as a technology and business development manager at the biotech firm Avitech Diagnostics for two years. [3]
Lawson obtained an MBA at Saïd Business School, University of Oxford in 1998. [7] She joined management consultancy McKinsey & Company in the same year. [3] Lawson was promoted to partner at the firm's London office and led its human capital practice across Europe, Middle East, and Africa, and co-wrote its 2012 report Women Matter 2012: Making the Breakthrough on improving gender diversity in business. [5] She joined supermarket chain Morrisons as their group Human Resources Director in September 2013. [8] Lawson left the company in 2015, [9] and joined Kingfisher plc as their Chief People Officer. [10] She left Kingfisher plc after a year. [11]
In November 2017, Lawson joined NHS England as their National Director for Transformation and Corporate Operations. She was responsible for business transformation and the integration of NHS Improvement into the organisation. [12] Lawson was promoted to Chief Commercial Officer (CCO) in early 2020. [13] She left this role to become the Senior Responsible Officer for the NHS COVID-19 vaccine deployment programme in November 2020 and led its initial rollout. [14] She was seconded to lead Prime Minister Boris Johnson's Delivery Unit for the summer of 2021 before returning to lead the vaccine booster programme in October 2021. [15] [16] [17] Lawson returned to lead the unit in 2022. [18] She left this role in August 2023 and returned to NHS England in October 2023 as its interim Chief Operating Officer replacing Jim Mackey. [19] [20] [21]
Lawson was appointed Dame Commander of the Order of the British Empire (DBE) in the 2022 New Year Honours for services to the NHS, particularly during the COVID-19 pandemic. [22] [23] She is a founding member of and deputy chair of the 30% Club which aims to improve gender diversity in business. [24]
The Therapeutic Goods Administration (TGA) is the medicine and therapeutic regulatory agency of the Australian Government. As part of the Department of Health and Aged Care, the TGA regulates the quality, supply and advertising of medicines, pathology devices, medical devices, blood products and most other therapeutics. Any items that claim to have a therapeutic effect, are involved in the administration of medication, or are otherwise covered by the Therapeutic Goods Act 1989, the Therapeutic Goods Regulations 1990, or a ministerial order, must be approved by the TGA and registered in the Australian Register of Therapeutic Goods.
The Joint Committee on Vaccination and Immunisation (JCVI) is an independent expert advisory committee that advises United Kingdom health departments on immunisation, making recommendations concerning vaccination schedules and vaccine safety. It has a statutory role in England and Wales, and health departments in Scotland and Northern Ireland may choose to accept its advice.
Scott John Morrison is an Australian politician who served as the 30th prime minister of Australia from 2018 to 2022, holding office as leader of the Liberal Party of Australia. He is currently the member of parliament (MP) for the New South Wales seat of Cook, a position he has held since 2007. On 23 January 2024, he announced that he will resign from politics at the end of February.
The Churchill Hospital is a teaching hospital in Oxford, England. It is managed by the Oxford University Hospitals NHS Foundation Trust.
Diana Mary "Dido" Harding, Baroness Harding of Winscombe is a British businesswoman and life peer who served as chair of NHS Improvement from 2017 to 2021 and as interim chief executive of the UK Health Security Agency (UKHSA) and head of NHS Test and Trace from 2020 to 2021.
Simon Laurence Stevens, Baron Stevens of Birmingham is Chair of Cancer Research UK and an independent member of the House of Lords. He served as the eighth Chief Executive of NHS England from 2014 to 2021.
Nikita "Nikki" Kanani MBE is a general practitioner and the former chief clinical officer of the Bexley Clinical Commissioning Group. In 2018 she became the first woman to be appointed medical director of primary care at NHS England.
Paula Anne Vennells is a British former businesswoman who was the chief executive officer of Post Office Limited from 2012 to 2019. She is also an Anglican priest.
Operation Rescript was the code name for the British military operation to help tackle the COVID-19 pandemic in the United Kingdom and its Crown Dependencies between 2020 and 2022. It was described as the UK's "biggest ever homeland military operation in peacetime" by the Ministry of Defence (MOD), involving up to 23,000 personnel within a specialist task force, named the COVID Support Force (CSF). The support was given at the request of the UK government, its devolved administrations and civil authorities through the Military aid to the civil authorities (MACA) mechanism.
Dame Catherine Elizabeth Bingham HonFMedSci is a British venture capitalist. She is a managing partner at a venture capital firm, SV Health Investors. In 2020, Bingham chaired the government's Vaccine Taskforce, steering procurement of vaccines during the COVID-19 pandemic in the United Kingdom.
Amanda Pritchard is a British healthcare official and public policy analyst who has been the Chief Executive of NHS England since 1 August 2021. Pritchard previously served as chief operating officer of NHS England and as chief executive of NHS Improvement from 2019 to 2021.She was formerly chief executive of Guy's and St Thomas' NHS Foundation Trust from January 2016 to July 2019, having been acting chief executive from October 2015 to January 2016.
The COVID-19 vaccination programme in the United Kingdom is an ongoing mass immunisation campaign for coronavirus disease 2019 (COVID-19) during the COVID-19 pandemic in the United Kingdom.
The following is a timeline of the COVID-19 pandemic in the United Kingdom from January 2021 to June 2021.
The following is a timeline of the COVID-19 pandemic in England during 2021. There are significant differences in the legislation and the reporting between the countries of the UK: England, Scotland, Northern Ireland, and Wales.
The general COVID-19 vaccination in Australia program began on 22 February 2021 in response to the COVID-19 pandemic, with the goal of vaccinating all willing people in Australia before 2022. Front-line workers and aged care staff and residents had priority for being inoculated, before a gradual phased release to less-vulnerable and lower-risk population groups throughout 2021. The Therapeutic Goods Administration (TGA) approved four vaccines for Australian use in 2021: the Pfizer–BioNTech vaccine on 25 January, the Oxford–AstraZeneca vaccine on 16 February, Janssen vaccine on 25 June and the Moderna vaccine on 9 August. Although approved for use, the Janssen vaccine was not included in the Australian vaccination program as of June 2021.
COVID-19 vaccination in New Zealand began on 20 February 2021, and will continue throughout the pandemic with the goal of vaccinating all willing New Zealanders aged 5 or older. Those aged 5 to 11 require a parent, caregiver or legal guardian accompany them to their appointment and provide consent for them to be vaccinated. As of 1 September, anyone in New Zealand, regardless of their immigration status, is eligible to be vaccinated.
The United Kingdom's response to the COVID-19 pandemic consists of various measures by the healthcare community, the British and devolved governments, the military and the research sector.
This article outlines the history of the COVID-19 pandemic in the United Kingdom. Though later reporting indicated that there may have been some cases dating from late 2019, COVID-19 was confirmed to be spreading in the UK by the end of January 2020. The country was initially relatively slow implementing restrictions but a legally enforced stay-at-home order had been introduced by late March. Restrictions were steadily eased across the UK in late spring and early summer that year.
The following is a timeline of the COVID-19 pandemic in England during 2022. There are significant differences in the legislation and the reporting between the countries of the UK: England, Scotland, Northern Ireland, and Wales.
The following is a timeline of the COVID-19 pandemic in the United Kingdom from July 2022 to December 2022.